Outcomes of the study groups after scheduled CD
c-STC group (n=1,867)
i-STC group (n=3,121)
Odds Ratio (95% Confidence Interval)
P-value
SSI rate, n (%) 50 (2.7) 140 (4.5) 1.66 (1.17-2.89) <0.0001
Re-admission within 6 weeks for SSI, n ‎‎(%)‎ 22 ( ‎0.9) ‎ ‎ 65 (1.7) ‎ 1.88 (1.23-3.21) ‎0.002‎
Maternal fever, n ‎‎(%)‎ 78 (3.2) 203 (5.3) 1.64 (1.12-2.45) 0.024
Duration of maternal ‎fever, days,‎ mean ± SD 3.2 ± 2.1 3.5 ± 2.4 1.09 (0.21-5.36) 0.62
Antibiotic use, n (%)‎ 67 (2.7) 165 (4.3) 1.57 (1.13-2.27) 0.038
Duration of ‎antibiotic use, days,‎ mean ± SD 7.9 ± 3.3 7.5 ± 3.8 1.05 (0.33-2.48) 0.56
CD-to-SSI time interval‎ days,‎ mean ± SD 3.1 ± 2.8 3.4 ± 2.9 1.09 (0.48-6.12) 0.49
Bacteremia and/or sepsis, n (%)‎ 13 (0.5) 28 (0.7) 1.41 (0.66-2.37) 0.33
Post-op hospitalization duration, days, ‎mean ± SD‎ 4.6 ± 2.3 4.9 ± 2.8 1.06 (0.31-3.34) 0.55